132 related articles for article (PubMed ID: 1323139)
21. [An evaluation of carcinoembryonic antigen (CEA), beta 2-microglobulin (BMG), and immunosuppressive acidic protein (IAP) in the serum of primary lung cancer patients].
Higuchi Y
Gan No Rinsho; 1986 Jan; 32(1):33-40. PubMed ID: 3005690
[TBL] [Abstract][Full Text] [Related]
22. Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients.
Ogushi F; Fukuoka M; Takada M; Tamai S; Sakai N; Negoro S; Okunaka N; Sone S; Tsubura E
Jpn J Clin Oncol; 1984 Sep; 14(3):321-7. PubMed ID: 6090732
[TBL] [Abstract][Full Text] [Related]
23. E rosettes in the uranium miners with lung cancer.
Kudrna K; Andrlíková J; Smíd A; Stipl Z
Czech Med; 1979; 2(3):141-7. PubMed ID: 231508
[TBL] [Abstract][Full Text] [Related]
24. [The skin tests in operability evaluation of patients with non-small cell cancer of the lungs].
Biondo FG; Caldarelli L; Bergaminelli C; Perillo G
Arch Monaldi Mal Torace; 1988; 43(3):265-70. PubMed ID: 2855917
[No Abstract] [Full Text] [Related]
25. Carcinoembryonic antigen fraction in lung cancer.
Fong S; Leon V; Betancourt M; Guarnaluse R
Neoplasma; 1983; 30(4):449-55. PubMed ID: 6310423
[TBL] [Abstract][Full Text] [Related]
26. [Serum levels of CEA and ferritin in lung cancer before, during and after radiotherapy].
Tatsuno I; Konishi K
Rinsho Hoshasen; 1983 Nov; 28(12):1487-90. PubMed ID: 6323796
[No Abstract] [Full Text] [Related]
27. Lung carcinoma: analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry.
Ito N; Nakamura H; Tanaka Y; Ohgi S
Cancer; 1999 Jun; 85(11):2359-67. PubMed ID: 10357406
[TBL] [Abstract][Full Text] [Related]
28. [Effect of hemodialysis using cuprophan and polysulfone dialyzers on rosette tests, concentration of immunoglobulins and complement components in serum of patients with chronic renal failure].
Starzyk J; Bartelik S; Sarnecka S
Wiad Lek; 1994 Jul; 47(13-14):523-6. PubMed ID: 7716940
[TBL] [Abstract][Full Text] [Related]
29. [Immunological aspects of lung cancer].
Miquel Muse I; Klempert H; Mazzara R; Rodrĩguez Villamil J; Allo G; Korc I
Torax; 1970 Dec; 19(4):222-31. PubMed ID: 5520152
[No Abstract] [Full Text] [Related]
30. [Tissue polypeptide antigen in serum and tissue in patients with lung cancer].
Haga E
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Apr; 28(4):595-604. PubMed ID: 2170727
[TBL] [Abstract][Full Text] [Related]
31. [Comparative study of serum lipid-bound sialic acid and carcinoembryonic antigen in patients with lung cancer].
Zhu X
Zhonghua Jie He He Hu Xi Za Zhi; 1990 Feb; 13(1):25-7, 61. PubMed ID: 2165867
[TBL] [Abstract][Full Text] [Related]
32. [Changes in the immune status of patients with cancer of the female genitalia].
Kis'ov V
Akush Ginekol (Sofiia); 1991; 30(1):22-4. PubMed ID: 1793132
[TBL] [Abstract][Full Text] [Related]
33. [Significance of CEA in sputum in examination of lung cancer].
Muraoka H; Katoh H; Moriya H; Kimura K; Higuchi Y
Rinsho Hoshasen; 1985 Mar; 30(3):379-84. PubMed ID: 2991629
[No Abstract] [Full Text] [Related]
34. [McAb LC-1 against human lung cancer].
Ge XR; Wang J; Lin SJ; Yu NX; Che YF; Gu Y
Shi Yan Sheng Wu Xue Bao; 1989 Sep; 22(3):359-65. PubMed ID: 2555985
[TBL] [Abstract][Full Text] [Related]
35. [Use of monoclonal antibodies for immunodiagnosis of lung cancer].
Romanova RI; Gergert VI; Filippov VP; Goncharskaia MA; Evgushchenko GV; Sidorova NF; Gorelova LA
Probl Tuberk; 1997; (5):44-8. PubMed ID: 9454255
[TBL] [Abstract][Full Text] [Related]
36. Increases in immunoglobulin and complement in patients with esophageal or gastric cancer.
Saito T; Kuwahara A; Kinoshita T; Shigemitsu Y; Shimoda K; Miyahara M; Kobayashi M
Surg Today; 1992; 22(6):537-42. PubMed ID: 1472794
[TBL] [Abstract][Full Text] [Related]
37. [Using two monoclonal antibodies to detect lung carcinoma associated antigen in the sera of patients with lung cancer by BA-ELISA].
Xue W; Hou J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Feb; 13(1):63-7. PubMed ID: 1652380
[TBL] [Abstract][Full Text] [Related]
38. Immunocompetence in lung cancer patients: analysis of serological and cellular parameters.
Pierri I; Rogna S; Tavano A; Setti M; Scudeletti M; Ratto G; Motta G; Indiveri F
Cancer Detect Prev; 1988; 13(2):95-101. PubMed ID: 3242825
[TBL] [Abstract][Full Text] [Related]
39. The detection of quantitative serum p53 protein in lung cancer.
Sen E; Gönüllü U; Akar N
Tuberk Toraks; 2005; 53(3):231-7. PubMed ID: 16258881
[TBL] [Abstract][Full Text] [Related]
40. [Humoral leukocyte adherence inhibition test in lung cancer].
Wei HM
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1985 Feb; 8(1):25-7, 61. PubMed ID: 2986918
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
